Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
PharmacoEconomics - United Kingdom
doi 10.1007/s40273-018-0680-z
Full Text
Open PDFAbstract
Available in full text
Date
June 27, 2018
Authors
Publisher
Springer Science and Business Media LLC